Evidence map›Paper›PMID 21091507›Full record

ArticleMolecular microbiology2010

Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.

Sandhya V Royan, Rheinallt M Jones, Athanasia Koutsouris, Jennifer L Roxas, Kanakeshwari Falzari, Andrew W Weflen, Amy Kim, Amy Bellmeyer, Jerrold R Turner, Andrew S Neish and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenicProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Article
  7. Review
  8. EnteropathogenicFrontiers in cellular and infection microbiology · 2020
    Article
  9. Review
  10. Review
  11. Hsp90 Interacts with the Bacterial Effector NleH1.Pathogens (Basel, Switzerland) · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. EnteropathogenicCellular and molecular gastroenterology and hepatology · 2018
    Article
  16. Structural host-microbiota interaction networks.PLoS computational biology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Sandhya V RoyanDepartment of Medicine, Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.
Rheinallt M Jones
Athanasia Koutsouris
Jennifer L Roxas
Kanakeshwari Falzari
Andrew W Weflen
Amy Kim
Amy Bellmeyer
Jerrold R Turner
Andrew S Neish
Ki-Jong Rhee
V K Viswanathan
Gail A Hecht
Emory University · USJesse Brown VA Medical Center · USUniversity of Arizona · USUniversity of Chicago · US

Funding

ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Transcriptional Regulation of NHE-3 Isoform in Human IntestineP01DK067887 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HECHT, GAIL A · 2006 to 2011
$4.9M
Enteropathogenic E. coli Effects on Intestinal FunctionR01DK050694 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HECHT, GAIL A · 1997 to 2010
$3.2M
ENTEROHEMORRHAGIC E COLI ALTER INTESTINAL FUNCTIONR01DK058964 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HECHT, GAIL A · 2000 to 2011
$2.8M
Pathogenic effector protein modulation of host innate immune signalingK01DK081481 · NIDDK · EMORY UNIVERSITY · PI JONES, RHEINALLT MELFYN · 2008 to 2010
$345k
NIDDK NIH HHS K01 DK081481NIDDK NIH HHS P01 DK067887NIDDK NIH HHS R01 DK050694NIDDK NIH HHS R01 DK058964NIDDK NIH HHS R01 DK061931
6 · The paper itself

Abstract

Enteric bacterial pathogens have evolved sophisticated strategies to evade host immune defences. Some pathogens deliver anti-inflammatory effector molecules into the host cell cytoplasm via a type III secretion system (T3SS). Enteropathogenic Escherichia coli (EPEC) inhibits inflammation by an undefined, T3SS-dependent mechanism. Two proteins encoded outside of the EPEC locus of enterocyte effacement (LEE) pathogenicity island, non-LEE-encoded effector H1 (NleH1) and H2 (NleH2), display sequence similarity to Shigella flexneri OspG, which inhibits activation of the pro-inflammatory transcription factor NF-κB. We hypothesized that the anti-inflammatory effects of EPEC were mediated by NleH1 and NleH2. In this study, we examined the effect of NleH1/H2 on the NF-κB pathway. We show that NleH1/H2 are secreted via the T3SS and that transfection of cells with plasmids harbouring nleH1 or nleH2 decreased IKK-β-induced NF-κB activity and attenuated TNF-α-induced degradation of phospho-IκBα by preventing ubiquitination. Serum KC levels were higher in mice infected with ΔnleH1H2 than those infected with WT EPEC, indicating that NleH1/H2 dampen pro-inflammatory cytokine expression. ΔnleH1H2 was cleared more rapidly than WT EPEC while complementation of ΔnleH1H2 with either NleH1 or NleH2 prolonged colonization. Together, these data show that NleH1 and NleH2 function to dampen host inflammation and facilitate EPEC colonization during pathogenesis.

Indexed as

AnimalsCell LineEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHEK293 CellsHumansI-kappa B ProteinsMaleMiceMice, Inbred C57BLNF-kappa BNF-KappaB Inhibitor alphaEscherichia coli ProteinsI-kappa B ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mouse

Identifiers

PMID21091507
PMCPMC3325542
OpenAlexW1938704217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.